The South & Central America home infusion therapy market is expected to grow from US$ 1,704.27 million in 2022 to US$ 2,587.96 million by 2028. It is estimated to grow at a CAGR of 7.2% from 2022 to 2028.
Addressing Unmet Needs of Patients Suffering from Oncological and Hematological Conditions is Driving South & Central America Home Infusion Therapy Market
With a dramatic shift toward homecare during the COVID-19 pandemic, the pharmaceutical and medical industries are focusing on developing various types of drugs to be administered in homecare settings, through the combination of pumps and professional services. The past decades have witnessed a shift in the delivery of chemotherapy from the hospital inpatient setting to the hospital outpatient setting to the specialized community practice setting. Furthermore, with developments in healthcare, a homecare setting is likely to become the place of care for the infusion of chemotherapy drugs. Companies in the home infusion therapy market are working on expanding their business by focusing on the unmet needs of patients. Globally, ~380 marketed infusion drugs and an additional 160 drugs are currently in the Phase 3 of drug development; more than 70% of these have an oncology or hematology indication. Thus, with growing efforts to launch infusion therapies for providing treatment of cancer and IDA at home is likely to fuel the home infusion therapy market growth during the forecast period.
South & Central America Home Infusion Therapy Market Overview
The South & Central America home infusion therapy market is segmented into Brazil, Argentina, and the Rest of South & Central America. The high burden of cancer, the increase in the geriatric population that is at a greater risk of cancer, and efforts by government to reduce the incidences of these diseases are among the factors contributing to the growth of home infusion therapy market in South & Central America. Brazil is among the largest economy in South & Central America. It is the fifth largest country across the world by area and population and experiencing the fastest demographic aging worldwide. As per the Brazil Statistical Institute, people in Brazil aged 65 and above are expected to hold a 36% share of the total population of the country by 2050. The rising geriatric population in Brazil leads to an increased incidence of various health conditions such as cardiovascular diseases (CVD), which may increase morbidities and demand for home services in the healthcare system. Thus, the rising aging population and growing diabetes cases in Brazil are likely to fuel the adoption of infusion therapy at home, which will eventually drive the growth of the home infusion therapy market in the country during the forecast period.
South & Central America Home Infusion Therapy Market Revenue and Forecast to 2028 (US$ Million)
South & Central America Home Infusion Therapy Market Segmentation
The South & Central America home infusion therapy market is segmented into product, application, route of administration and country.
Based on product, the home infusion therapy market is segmented into infusion pumps, intravenous sets, IV cannulas, and needleless connectors. The home infusion therapy market segment is sub segmented into insulin pumps, elastomeric pumps, syringe pumps, and others. The infusion pumps segment held the largest market share in 2022.
Based on application, the home infusion therapy market is segmented into enteral nutrition, anti-infective, endocrinology, hydration therapy, chemotherapy, specialty pharmaceuticals, and others. The anti-infective segment held the largest share of the market in 2022.
Based on route of administration, the home infusion therapy market is segmented into intramuscular, subcutaneously, and epidural. The intramuscular segment held the largest share of the market in 2022.
Based on country, the South & Central America home infusion therapy market is segmented into Brazil, Argentina, and the Rest of South & Central America. The Rest of South & Central America dominated the market in 2022.
B. Braun Melsungen AG; Baxter International Inc; Nipro Corp; Becton Dickinson and Co; Fresenius Kabi AG; ICU Medical Inc; Terumo Corp are the leading companies operating in the South & Central America home infusion therapy market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 1,704.27 Million |
| Market Size by 2028 | US$ 2,587.96 Million |
| CAGR (2022 - 2028) | 7.2% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By Product
|
| Regions and Countries Covered |
South and Central America
|
| Market leaders and key company profiles |
|
The South & Central America Home Infusion Therapy Market is valued at US$ 1,704.27 Million in 2022, it is projected to reach US$ 2,587.96 Million by 2028.
As per our report South & Central America Home Infusion Therapy Market, the market size is valued at US$ 1,704.27 Million in 2022, projecting it to reach US$ 2,587.96 Million by 2028. This translates to a CAGR of approximately 7.2% during the forecast period.
The South & Central America Home Infusion Therapy Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Home Infusion Therapy Market report:
The South & Central America Home Infusion Therapy Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South & Central America Home Infusion Therapy Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South & Central America Home Infusion Therapy Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For South & Central America Home Infusion Therapy Market
